3 Sep 2021

Intranasal Immunization: Promises and Challenges

JPG 1.1 MB

Today, there are three marketed nasal vaccines available for human use but many more are in development for both human and veterinary use.Nasal vaccination provides an alternative to the more conventional Injectable drug delivery system. Mucosal immunity can develop via interaction with immune modulators present in the nasal cavity, where the nasal associated lymphoid tissue (NALT) region plays a dominant role

Content provided by our supplier

Aptar Pharma

  • FR
  • 2015
    On CPHI since
  • 5000+
Company types
Packaging supplier/manufacturer

Other Content from Aptar Pharma (39)